Stefano Aliberti

Papers

Total Citations

H-Index

About

Stefano Aliberti is a leading figure in respiratory medicine, whose research has fundamentally reshaped our understanding of bronchiectasis, pneumonia, and non-tuberculous mycobacterial (NTM) lung disease. As a Professor of Respiratory Medicine at the University of Milan and Director of the Respiratory Unit at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Aliberti has been instrumental in establishing international guidelines and classification systems for bronchiectasis, a chronic condition that was historically neglected. His work on the EMBARC registry has provided critical epidemiological data, revealing the true burden of the disease across Europe. With an h-index exceeding 60 and over 15,000 citations, his impact is profound. He has led landmark clinical trials, including those investigating inhaled antibiotics and novel anti-inflammatory therapies for bronchiectasis. Aliberti also spearheaded the development of the FACED and BSI severity scores, which are now standard tools for risk stratification. His recent contributions extend to postoperative pneumonia in lung cancer surgery, identifying key risk factors and pathogens to improve patient outcomes. A prolific author and frequent keynote speaker, Aliberti continues to drive innovation in respiratory care, bridging the gap between bench research and bedside practice.